1D-AL-LAD

1D-AL-LAD, also known as 1-(1,2-dimethylcyclobutane-1-carbonyl)-AL-LAD, is a psychedelic drug of the lysergamide family related to AL-LAD. It is thought to be a prodrug of AL-LAD similarly to how 1D-LSD is a prodrug of LSD. 1D-AL-LAD was encountered online as a novel designer drug in 2023 and 2024. It is said to have a dose of 100 to 300 μg orally, a time to peak effects of 2 to 2.5 hours, and a duration of 12 hours. The drug is said have "half the intensity" of LSD, with its effects including psychedelic visuals among others. Although 1D-AL-LAD has reported to have been sold, some or all of the sold product appears to have actually been mislabeled 1T-AL-LAD. 1D-AL-LAD is not an explicitly controlled substance in the United States or in Canada.

Classification

Chemical: Lysergamide
Psychoactive: Psychedelic

Effects

Dilated Pupils
Stimulation
Nausea
Pupil Dilation
Spontaneous Tactile Sensations
Introspection
Euphoria
Time Distortion
Conceptual Thinking
Analysis Enhancement
Memory Suppression
Visual Distortion
Color Enhancement
Tracers
Pattern Recognition Enhancement
Drifting

Routes of Administration

No route information available yet.

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

wikipedia.org

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu